$3.45
-0.04-1.15%
At Close: -
$3.49
0.041.16%
After Hours: Jul 5, 8:17 AM EDT
15 minutes delayed
Autolus Therapeutics
AUTLNASDAQ
want to know what
the Bulls & Bears Say?
Autolus Therapeutics (NASDAQ:AUTL) Stock, Analyst Ratings, Price Targets, Forecasts
Autolus Therapeutics PLC has a consensus price target of $8.72 based on the ratings of 26 analysis. The 3 most-recent analyst ratings were released by Needham, Needham, and Needham on June 17, 2024, June 3, 2024, and May 17, 2024, respectively. With an average price target of $9 between Needham, Needham, and Needham, there's an implied 157.88% upside for Autolus Therapeutics PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
Truist Securities
Goldman Sachs
Deutsche Bank
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Autolus Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/17/2024 | Buy Now | 157.88% | Needham | Gil Blum | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 157.88% | Needham | Gil Blum | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2024 | Buy Now | 157.88% | Needham | Gil Blum | → $9 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2024 | Buy Now | 157.88% | Needham | Gil Blum | → $9 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | Buy Now | 215.19% | Truist Securities | Gil Blum | $10 → $11 | Maintains | Buy | Get Alert |
| 03/18/2024 | Buy Now | 186.53% | Truist Securities | Gil Blum | $9 → $10 | Maintains | Buy | Get Alert |
| 03/14/2024 | Buy Now | 157.88% | Needham | Gil Blum | $9 → $9 | Maintains | Buy | Get Alert |
| 02/12/2024 | Buy Now | 157.88% | Needham | Gil Blum | $8 → $9 | Maintains | Buy | Get Alert |
| 01/22/2024 | Buy Now | 129.23% | Needham | Gil Blum | $7 → $8 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | 37.54% | Goldman Sachs | — | $3.2 → $4.8 | Maintains | Neutral | Get Alert |
| 11/29/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | Buy Now | 186.53% | Deutsche Bank | James Shin | → $10 | Initiates | → Buy | Get Alert |
| 10/25/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | Buy → Buy | Get Alert |
| 08/17/2023 | Buy Now | 157.88% | Truist Securities | Asthika Goonewardene | $6 → $9 | Maintains | Buy | Get Alert |
| 06/05/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | → Buy | Get Alert |
| 05/05/2023 | Buy Now | 71.92% | Wells Fargo | Vanck Zhu | $8 → $6 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | → Buy | Get Alert |
| 04/28/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | → Buy | Get Alert |
| 04/21/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | → Buy | Get Alert |
| 03/27/2023 | Buy Now | 129.23% | Wells Fargo | Yanan Zhu | → $8 | Assumes | → Overweight | Get Alert |
| 03/08/2023 | Buy Now | 243.84% | Mizuho | Mara Goldstein | $18 → $12 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 100.57% | Needham | Gil Blum | → $7 | Reiterates | → Buy | Get Alert |
| 12/09/2022 | Buy Now | 100.57% | Needham | Gil Blum | $12 → $7 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | 243.84% | Needham | Gil Blum | $13 → $12 | Maintains | Buy | Get Alert |
| 06/14/2022 | Buy Now | 215.19% | Truist Securities | Asthika Goonewardene | $13 → $11 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ:AUTL) was reported by Needham on June 17, 2024. The analyst firm set a price target for $9.00 expecting AUTL to rise to within 12 months (a possible 157.88% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Autolus Therapeutics (AUTL)?
The latest analyst rating for Autolus Therapeutics (NASDAQ:AUTL) was provided by Needham, and Autolus Therapeutics reiterated their buy rating.
When was the last upgrade for Autolus Therapeutics (AUTL)?
There is no last upgrade for Autolus Therapeutics
When was the last downgrade for Autolus Therapeutics (AUTL)?
There is no last downgrade for Autolus Therapeutics.
When is the next analyst rating going to be posted or updated for Autolus Therapeutics (AUTL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Autolus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Autolus Therapeutics was filed on June 17, 2024 so you should expect the next rating to be made available sometime around June 17, 2025.
Is the Analyst Rating Autolus Therapeutics (AUTL) correct?
While ratings are subjective and will change, the latest Autolus Therapeutics (AUTL) rating was a reiterated with a price target of $9.00 to $9.00. The current price Autolus Therapeutics (AUTL) is trading at is $3.49, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.